Oncology collaboration established to accelerate translational cancer research Read more Blood test picks out cancers likely to benefit from targeted drugs Read more here Shorter radiotherapy course reduces risk of bladder cancer returning Read morePreviousNext Highlights Research is key to future treatment Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients. Patient and public involvement and engagement Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer. Find out more Latest news Shorter radiotherapy courses well tolerated long-term Research indicates fewer, higher intensity doses of radiotherapy, is as well tolerated as longer treatment courses for prostate cancer. Find out more Drug combination could extend time between treatments A combination of immunotherapy and a targeted therapy could extend time between treatments for some women with recurrent ovarian cancer. Find out more Drug combination shows promise in advanced ovarian cancer A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more More information Upcoming events Patient and public involvement and engagement BRC training hub Magazine articles
